HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vittoria Cenni Selected Research

Autosomal Emery-Dreifuss Muscular Dystrophy

1/2019Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies.
1/2017Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vittoria Cenni Research Topics

Disease

9Laminopathies
01/2020 - 06/2005
7Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
01/2020 - 04/2003
4Lipodystrophy
01/2021 - 06/2005
4Familial Partial Lipodystrophy (Dunnigan Syndrome)
10/2012 - 11/2003
3Progeria (Hutchinson Gilford Syndrome)
11/2016 - 07/2010
2Scleroatonic muscular dystrophy
01/2022 - 11/2020
2Muscular Dystrophies (Muscular Dystrophy)
01/2022 - 04/2011
2Neoplasms (Cancer)
01/2021 - 12/2004
2Autosomal Emery-Dreifuss Muscular Dystrophy
01/2019 - 01/2017
2Werner Syndrome (Werner's Syndrome)
07/2010 - 06/2005
1Rhabdomyosarcoma
04/2022
1Alzheimer Disease (Alzheimer's Disease)
11/2021
1Carcinogenesis
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1Kyphosis
01/2021
1Contracture
11/2020
1Bethlem myopathy
11/2020
1Joint Instability (Joint Laxity)
11/2020
1Muscle Weakness
11/2020
1Muscular Diseases (Myopathy)
11/2020
1Inflammation (Inflammations)
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
04/2011
1Necrosis
11/2003

Drug/Important Bio-Agent (IBA)

12Lamin Type A (Lamin A)IBA
01/2020 - 04/2003
6Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2003
6prelamin AIBA
01/2020 - 06/2005
5LaminsIBA
01/2019 - 11/2003
4emerinIBA
01/2020 - 04/2003
2CollagenIBA
01/2022 - 11/2020
2Carrier Proteins (Binding Protein)IBA
01/2019 - 04/2011
2ChromatinIBA
03/2016 - 07/2010
1idelalisibIBA
04/2022
1Glycogen Synthase KinasesIBA
11/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1MicroRNAs (MicroRNA)IBA
01/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1MTOR InhibitorsIBA
11/2016
1Sirolimus (Rapamycin)FDA Link
11/2016
1Therapeutic UsesIBA
11/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1Peptides (Polypeptides)IBA
04/2011
1lamina-associated polypeptide 2IBA
04/2011
1Nuclear Matrix-Associated ProteinsIBA
04/2011
1Lamin Type B (Lamin B)IBA
04/2011
1Protein PrecursorsIBA
07/2010
1PPAR gammaIBA
06/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2005
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2004
1CytokinesIBA
12/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2004
1Interleukin-1 (Interleukin 1)IBA
11/2003
1Phosphotransferases (Kinase)IBA
11/2003
1NF-kappa B (NF-kB)IBA
11/2003